Rheumatoid Factor Level Increased by the Tocilizumab in Rheumatoid Arthritis Patients with Good Clinical Response

被引：0
|
作者：
Kaliterna, Dusanka Martinovic [1 ]
Radic, Mislav [1 ]
Perkovic, Dijana [1 ]
Krstulovic, Daniela Marasovic [1 ]
Marinovic, Ivanka [2 ]
Boric, Katarina [1 ]
Aljinovic, Jure [2 ]
机构：
[1] Univ Hosp Split, Sch Med Split, Dept Rheumatol & Clin Immunol, Split, Croatia
[2] Univ Hosp Split, Sch Med Split, Dept Rehabil Med & Rheumatol, Split, Croatia
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2014年 / 32卷 / 04期
关键词：
Rheumatoid factor; tocilizumab; rheumatoid arthritis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-127
引用
收藏
页码：S39 / S39
页数：1
相关论文
共 50 条
  • [31] Rheumatoid factor appearance after tocilizumab treatment seems to predict bad therapeutical response in rheumatoid arthritis
    Faillace, Cesar
    de Carvalho, Jozelio Freire
    RHEUMATOLOGY INTERNATIONAL, 2013, 33 (07) : 1909 - 1910
  • [32] Comparison of the clinical effectiveness of tumour necrosis factor inhibitors and abatacept after insufficient response to tocilizumab in patients with rheumatoid arthritis
    Mitsuhiro Akiyama
    Yuko Kaneko
    Harumi Kondo
    Tsutomu Takeuchi
    Clinical Rheumatology, 2016, 35 : 2829 - 2834
  • [33] Comparison of the clinical effectiveness of tumour necrosis factor inhibitors and abatacept after insufficient response to tocilizumab in patients with rheumatoid arthritis
    Akiyama, Mitsuhiro
    Kaneko, Yuko
    Kondo, Harumi
    Takeuchi, Tsutomu
    CLINICAL RHEUMATOLOGY, 2016, 35 (11) : 2829 - 2834
  • [34] Tocilizumab Induced Acquired Factor XIII Deficiency in Patients with Rheumatoid Arthritis
    Mokuda, Sho
    Murata, Yosuke
    Sawada, Naoya
    Matoba, Kenichiro
    Yamada, Akihiro
    Onishi, Makoto
    Okuda, Yasuaki
    Jouyama, Kazuo
    Sugiyama, Eiji
    Takasugi, Kiyoshi
    PLOS ONE, 2013, 8 (08):
  • [35] Doppler ultrasound impacts response to intravenous tocilizumab in rheumatoid arthritis patients
    Nicolette T. Morris
    Jenny Brook
    Ami Ben-Artzi
    William Martin
    Tanaz A. Kermani
    Lynette Avedikian-Tatosyan
    George Karpouzas
    Himakar Nagam
    Geraldine Navarro
    Soo Choi
    Mihaela B. Taylor
    David Elashoff
    Gurjit S. Kaeley
    Veena K. Ranganath
    Clinical Rheumatology, 2021, 40 : 5055 - 5065
  • [36] Predictors of response and remission in a large cohort of rheumatoid arthritis patients treated with tocilizumab in clinical practice
    Pers, Yves-Marie
    Fortunet, Clementine
    Constant, Elodie
    Lambert, Joseph
    Godfrin-Valnet, Marie
    De Jong, Audrey
    Mercier, Gregoire
    Prades, Beatrice Pallot
    Wendling, Daniel
    Gaudin, Philippe
    Jorgensen, Christian
    Marotte, Hubert
    Maillefert, Jean-Francis
    RHEUMATOLOGY, 2014, 53 (01) : 76 - 84
  • [37] THE EFFECT OF BODYWEIGHT ON RESPONSE TO INTRAVENOUS OR SUBCUTANEOUS TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Davies, R.
    Vivekanantham, A.
    Lunt, M.
    Watson, K.
    Hyrich, K.
    Bluett, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 981 - 981
  • [38] DIFFERENTIAL DNA METHYLATION AS A PREDICTOR OF TOCILIZUMAB RESPONSE IN RHEUMATOID ARTHRITIS PATIENTS
    Nair, N.
    Plant, D.
    Isaacs, J.
    Morgan, A.
    Hyrich, K.
    Barton, A.
    Wilsonon, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 220 - 220
  • [39] Clinical efficacy of tocilizumab in patients with active rheumatoid arthritis in real clinical practice
    Yasuhiko Hirabayashi
    Tomonori Ishii
    Hideo Harigae
    Rheumatology International, 2010, 30 : 1041 - 1048
  • [40] Doppler ultrasound impacts response to intravenous tocilizumab in rheumatoid arthritis patients
    Morris, Nicolette T.
    Brook, Jenny
    Ben-Artzi, Ami
    Martin, William
    Kermani, Tanaz A.
    Avedikian-Tatosyan, Lynette
    Karpouzas, George
    Nagam, Himakar
    Navarro, Geraldine
    Choi, Soo
    Taylor, Mihaela B.
    Elashoff, David
    Kaeley, Gurjit S.
    Ranganath, Veena K.
    CLINICAL RHEUMATOLOGY, 2021, 40 (12) : 5055 - 5065
12345